March 15, 2017 / 10:43 PM / 4 months ago

BRIEF-Conatus Pharma qtrly loss per share $0.35

1 Min Read

March 15 (Reuters) - Conatus Pharmaceuticals Inc

* Conatus pharmaceuticals reports 2016 financial results and program updates

* Q4 revenue $800,000

* Q4 revenue view $1.7 million -- Thomson Reuters I/B/E/S

* Qtrly loss per share $0.35 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below